Your browser doesn't support javascript.
loading
A Case of Basal Cell Carcinoma Treated with Combination of CO2 Laser and 5% Imiquimod Cream / 대한피부과학회지
Korean Journal of Dermatology ; : 1187-1190, 2007.
Article Dans Coréen | WPRIM | ID: wpr-116303
ABSTRACT
Basal cell carcinoma is the most common skin cancer and surgical treatments like Mohs surgery have been accepted as ideal for it. Although surgical treatments are very effective, non-invasive treatments such as electrocauterization, cryosurgery, CO2 laser and topical 5-fluorouracil cream have been tried because patients need more simple procedures and better cosmetic results. Imiquimod is a Toll-like receptor 7 agonist and which acts as an immune response modifier by inducing several cytokines including interferon. Previously, many reports showed the usefulness of 5% imiquimod cream in treating basal cell carcinoma. However, some local adverse effects, long treatment time and limitation of deep penetration are problems to be resolved. We tried 5% imiquimod cream application after the removal of a visible basal cell carcinoma using CO2 laser, which gave satisfactory results.
Sujets)

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Tumeurs cutanées / Carcinome basocellulaire / Cytokines / Chirurgie de Mohs / Interférons / Cryochirurgie / Récepteur de type Toll-7 / Lasers à gaz / Fluorouracil Limites du sujet: Humains langue: Coréen Texte intégral: Korean Journal of Dermatology Année: 2007 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Tumeurs cutanées / Carcinome basocellulaire / Cytokines / Chirurgie de Mohs / Interférons / Cryochirurgie / Récepteur de type Toll-7 / Lasers à gaz / Fluorouracil Limites du sujet: Humains langue: Coréen Texte intégral: Korean Journal of Dermatology Année: 2007 Type: Article